1/63
Looks like no tags are added yet.
Name | Mastery | Learn | Test | Matching | Spaced |
---|
No study sessions yet.
What is the definition of PANCREATIC TUMORS?
Pancreatic tumors are most commonly ductal adenocarcinoma, often located in the pancreatic head. They are usually asymptomatic in early stages but can present with belt-like epigastric pain that radiates to the back.
What is the epidemiology of PANCREATIC TUMORS?
Pancreatic tumors typically affect individuals 60-80 years old and have an extremely poor prognosis. This includes very low 1-year and 5-year relative survival rates across all stages.
What are the risk factors of PANCREATIC TUMORS?
Risk factors for pancreatic tumors include smoking, high alcohol consumption, and chronic pancreatitis.
What are the clinical features of PANCREATIC TUMORS?
Clinical features can include belt-like epigastric pain radiating to the back, jaundice, and an enlarged gallbladder. Patients may also experience weight loss, poor appetite, pale stools, dark urine, pruritus, and various forms of thrombosis.
What are the signs of PANCREATIC TUMORS?
Jaundice affecting skin, tongue, and eyes can be observed, along with ascites upon abdominal palpation. Courvoisier sign, characterized by an enlarged, painless gallbladder with jaundice, and Trousseau syndrome, involving recurring thrombophlebitis, are also classic signs.
What are the symptoms of PANCREATIC TUMORS?
Early stages are often asymptomatic, but later symptoms can include belt-like epigastric pain radiating to the back. Other symptoms are pruritus, decreased appetite, weight loss, nausea, weakness, and diarrhoea, possibly due to exocrine pancreas insufficiency.
What are the diagnostic methods of PANCREATIC TUMORS and their positive results?
Diagnosis involves blood tests showing increased lipase, and tumor markers like CA 19-9 and CEA. Imaging includes abdominal CT, which may reveal a double-duct sign, and endoscopic ultrasound to determine cancer location and size. Needle biopsy or excision is also used, and staging is done by CT. ERCP/MRCP can rule out choledocholithiasis if biliary decompression is needed.
What are the treatment methods of PANCREATIC TUMORS?
Treatment options include surgical resection, often the Whipple procedure for localized disease in the pancreatic head. Adjuvant or neoadjuvant chemoradiotherapy can be offered to reduce tumor size and prolong life, though it cannot cure without surgery. For inoperable patients, palliative chemotherapy, pain management (analgesia), and procedures like celiac plexus block or stent implantation for cholestasis are used.
What is the palliative treatment of PANCREATIC TUMORS?
Palliative treatment includes chemotherapy and analgesia for pain management. For cholestasis, ERCP with stent implantation or Percutaneous transhepatic bile duct drainage (PTCD) can be performed. Other palliative interventions include gastroenterostomy for gastric outlet stenosis, celiac plexus block for pain, and PEG tube insertion for severe palliative patients with chronic ileus.
What is the surgical treatment of PANCREATIC TUMORS?
Surgical resection is suitable for about 20% of patients with localized disease. For pancreatic head carcinoma, the Whipple procedure (pancreaticoduodenectomy) is most common, involving resection of the pancreatic head, duodenum, gallbladder, and bile duct, with reattachment of remaining organs for digestion. This includes creating a gastrojejunostomy for food bypass and a cholecystojejunostomy to drain bile. A modified Whipple, the pylorus-preserving pancreaticoduodenectomy, can preserve parts of the stomach and duodenum for more physiologic emptying. For pancreatic body and tail carcinoma, resection of the left side of the pancreas with splenectomy is performed.
What are the complications of PANCREATIC TUMORS?
Complications include lymphogenic and hematogenous metastasis, which can occur early to lymph nodes and liver, and later to visceral organs like the duodenum, stomach, colon, and lungs. Other complications are stenosis leading to gastric outlet obstruction or common bile duct cholestasis, secondary diabetes, and disseminated intravascular coagulation (DIC).